-
Altimmune: Q4 Earnings Insights
Thursday, March 5, 2026 - 8:28am | 140Read More...Altimmune (NASDAQ:ALT) released its Q4 earnings on Thursday, March 5, 2026 at 07:00 AM. Here's what's important from the earnings announcement. Earnings Altimmune missed estimated earnings by -8.0%, reporting an EPS of $-0.27 versus an estimate of $-0.25. Revenue was up $21 thousand from the same...
-
Alcon Earnings Report: Q4 Overview
Thursday, March 5, 2026 - 8:16am | 314Read More...Alcon (NYSE:ALC) reported its Q4 earnings results on Tuesday, February 24, 2026 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Alcon missed estimated earnings by -7.14%, reporting an EPS of $0.78 versus an estimate of $0.84. Revenue was up $225.00 million from the...
-
Immatics Earnings Report: Q4 Overview
Thursday, March 5, 2026 - 8:14am | 162Read More...The Q4 earnings report for Immatics (NASDAQ:IMTX) was released on Thursday, March 5, 2026 at 07:00 AM. Here's what investors need to know about the latest announcement. Earnings Immatics beat estimated earnings by 29.17%, reporting an EPS of $-0.34 versus an estimate of $-0.48. Revenue was down $37...
-
Evogene Earnings Review: Q4 Summary
Thursday, March 5, 2026 - 8:10am | 263Read More...Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 5, 2026 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Evogene missed estimated earnings by -134.62%, reporting an EPS of $-0.61 versus an estimate of $-0.26. Revenue was down $1.30 million...
-
Bioventus Q4 Earnings Assessment
Thursday, March 5, 2026 - 8:10am | 296Read More...Bioventus (NASDAQ:BVS) announced its Q4 earnings on Thursday, March 5, 2026 at 07:00 AM. Here's a breakdown of the earnings report. Earnings Bioventus beat estimated earnings by 9.09%, reporting an EPS of $0.24 versus an estimate of $0.22. Revenue was up $4.26 million from the same period last year...
-
Invivyd Q4 Earnings Assessment
Thursday, March 5, 2026 - 8:10am | 260Read More...Invivyd (NASDAQ:IVVD) announced its Q4 earnings on Thursday, March 5, 2026 at 07:00 AM. Here's a breakdown of the earnings report. Earnings Invivyd beat estimated earnings by 125.0%, reporting an EPS of $0.02 versus an estimate of $-0.08. Revenue was up $3.39 million from the same period last year...
-
Regenxbio Earnings Report: Q4 Overview
Thursday, March 5, 2026 - 8:10am | 260Read More...Regenxbio (NASDAQ:RGNX) just disclosed its Q4 earnings on Thursday, March 5, 2026 at 07:05 AM. Here's a brief overview of the earnings report. Earnings Regenxbio missed estimated earnings by -42.86%, reporting an EPS of $-1.3 versus an estimate of $-0.91. Revenue was up $9.12 million from the same...
-
CPI Card Q4 Earnings Report: What Investors Need to Know
Thursday, March 5, 2026 - 8:04am | 261Read More...The earnings results for CPI Card (NASDAQ:PMTS) for Q4 were made public on Thursday, March 5, 2026 at 07:00 AM. Here's a comprehensive overview of the announcement. Earnings CPI Card beat estimated earnings by 1.64%, reporting an EPS of $0.62 versus an estimate of $0.61. Revenue was up $27.96...
-
Capital Clean Energy Q4 Earnings Assessment
Thursday, March 5, 2026 - 8:04am | 259Read More...Capital Clean Energy (NASDAQ:CCEC) announced its Q4 earnings on Thursday, March 5, 2026 at 07:00 AM. Here's a breakdown of the earnings report. Earnings Capital Clean Energy beat estimated earnings by 14.29%, reporting an EPS of $0.48 versus an estimate of $0.42. Revenue was down $6.77 million from...
-
Bioventus Earnings Report: Q4 Overview
Thursday, March 5, 2026 - 8:04am | 301Read More...The earnings results for Bioventus (NASDAQ:BVS) for Q4 were made public on Thursday, March 5, 2026 at 07:30 AM. Here's a comprehensive overview of the announcement. Earnings Bioventus beat estimated earnings by 9.09%, reporting an EPS of $0.24 versus an estimate of $0.22. Revenue was up $4.26...
-
Lexicon Pharmaceuticals Q4 Earnings Summary & Key Takeaways
Thursday, March 5, 2026 - 8:02am | 264Read More...Lexicon Pharmaceuticals (NASDAQ:LXRX) just disclosed its Q4 earnings on Thursday, March 5, 2026 at 07:30 AM. Here's a brief overview of the earnings report. Earnings Lexicon Pharmaceuticals beat estimated earnings by 42.86%, reporting an EPS of $-0.04 versus an estimate of $-0.07. Revenue was down...
-
Tango Therapeutics Q4 Earnings Summary & Key Takeaways
Thursday, March 5, 2026 - 8:02am | 284Read More...Tango Therapeutics (NASDAQ:TNGX) reported its Q4 earnings results on Thursday, March 5, 2026 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Tango Therapeutics beat estimated earnings by 9.38%, reporting an EPS of $-0.29 versus an estimate of $-0.32. Revenue was...
-
Earnings Summary: Victoria's Secret Q4
Thursday, March 5, 2026 - 8:02am | 261Read More...The Q4 earnings report for Victoria's Secret (NYSE:VSCO) was released on Thursday, March 5, 2026 at 07:00 AM. Here's what investors need to know about the latest announcement. Earnings Victoria's Secret beat estimated earnings by 10.36%, reporting an EPS of $2.77 versus an estimate of $2.51....
-
Myers Indus Q4 Earnings Assessment
Thursday, March 5, 2026 - 8:02am | 260Read More...The Q4 earnings report for Myers Indus (NYSE:MYE) was released on Thursday, March 5, 2026 at 07:00 AM. Here's what investors need to know about the latest announcement. Earnings Myers Indus beat estimated earnings by 34.78%, reporting an EPS of $0.31 versus an estimate of $0.23. Revenue was up $98...
-
Ciena Q1 Earnings Assessment
Thursday, March 5, 2026 - 8:02am | 253Read More...Ciena (NYSE:CIEN) reported its Q1 earnings results on Thursday, March 5, 2026 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Ciena beat estimated earnings by 28.57%, reporting an EPS of $1.35 versus an estimate of $1.05. Revenue was up $355.04 million from the same...








